image

Neuroendoscopy Market Report Scope And Overview:

The Neuroendoscopy Market size is projected to grow from $151.07 million in 2023 to $237.05 million by 2031, at a CAGR of 5.8% during the forecast period.

The rising number of brain tumor cases worldwide and the rising need for minimally invasive surgical procedures are driving up demand for neuroendoscopy. These medical devices are primarily utilized in the treatment of conditions like hydrocephalus, bleeding, intraventricular hemorrhage, and pituitary tumors. Consequently, the market is expanding due to the steady increase in the prevalence of pituitary tumors and intraventricular hemorrhage.

Neuroendoscopy Market Revenue Analysis

Get More Information on Neuroendoscopy Market - Request Sample Report

Conventional brain surgical techniques, like craniotomies, involve a full skull opening and are intricate and invasive. There is a significant chance of stroke, bleeding, blindness, deafness, and occasionally even death with these procedures. A minimally invasive procedure's chance of developing the conditions listed above is low. Due to neuroendoscopy's minimally invasive nature, demand for the procedure is rising steadily.

MARKET DYNAMICS

Drivers

  • Growing Technological Advancements Made by Industry Participants

Technological advancements are driving a significant trend in the market growth rate. The growing inclination towards minimally invasive surgical procedures has prompted the advancement of sophisticated neuroendoscopy technologies. Surgeons can now operate with increased precision and accuracy thanks to a number of developments in endoscopy imaging and visualization systems. Neuroendoscopic surgery visualization has also been enhanced by the advent of 4K ultra-high-definition monitors and 3D endoscopy technologies. This element thus promotes market expansion.

  • Demand for Flexible Neuroendoscopes Is Growing

The demand for flexible neuroendoscopes is expected to increase due to the many benefits of flexible neuroendoscopy. The fact that flexible neuroendoscopes have unstable geometry and can be paved along a curved trajectory is one of their main advantages. Take Karl Storz GmbH's "flexible video neuroendoscope," which was created to treat hydrocephalus. It is the only video neuroendoscope that the Food and Drug Administration (FDA) has approved. Thus, market expansion is a result of this factor.

Restraint

  • Inadequate Professionals in Developing Nations, Exorbitant Surgical and Device Expenses

The lack of qualified neuroendoscopy professionals in developing nations has stunted the market's expansion. Approximately 23,300 neurosurgeons were needed to treat the more than 5 million neurosurgical cases that were currently in existence, according to a recent study that was published in the Journal of Neurosurgery.

Medical institutions favour conventional methods due to the high costs of devices, which hinders the growth of the industry. Additionally, patients are forced to choose alternative treatments due to the high cost of minimally invasive neurosurgery, which hinders the market's growth. An endoscopic third ventriculostomy can cost up to $2200, per an NCBI study.

Opportunities

  • Growing Numbers of Brain Tumor Cases

Due to an increase in brain tumor cases worldwide, the market is anticipated to expand during the forecast period. For both, brain and other nervous system cancer ranks as the tenth most common cause of death. Primary cancerous brain and central nervous system tumors are predicted to cause 18,990 deaths in the United States in 2023. Radiation exposure and a family history of brain tumors are the main risk factors. The growing number of brain tumors necessitates the extensive use of neuroendoscopy, which will aid in accurately identifying and assessing the tumor. This element thus promotes market expansion.

  • Hospital Neuroendoscopy Demand Is Rising

The demand from hospitals for neuroendoscopy is high, and this trend is anticipated to continue throughout the forecast period. This is because more patients are having neuroendoscopy procedures performed in hospitals, and there is a greater need for infrastructure and specialized medical staff. The market is growing because there are more hospitals and operating rooms performing neuroendoscopy procedures. Thus, market expansion is a result of this factor.  

Challenges

  • Adverse Events Linked to Neuroendoscopy

Neuroendoscopy has a number of side effects that can hinder the market. These procedures can result in subdural hematomas, pneumocephalus, subdural hygromas, and damage to the hypothalamus and basilar artery. Additionally, a number of side effects, like bleeding, infections, or anesthesia-related reactions, hinder market expansion. As a result, these elements impede market expansion.

IMPACT OF RUSSIAN UKRAINE WAR

Millions of civilians are displaced and vital infrastructure is destroyed as a result of the conflict in Ukraine, and the demand for neurosurgical care has skyrocketed. To date, it is unknown how this armed conflict will affect neurosurgery practice.

Already, 57% of the participants have been made to perform surgery on patients who are not specialists in their field. Of those who reported war-related trauma to the central nervous system, 78% identified traumatic brain injury (TBI) as the most common Surgery, while 22% reported spinal cord injuries as the most common. Ninety-six participants said they had no ongoing contact with their Russian neurosurgical colleagues, two said they had, and four denied the answer when asked.

The attacks partially injured the Ukrainian neurosurgeons personally, made them work in unfavorable environments, and caused them to perform procedures outside of their usual scope of practice.

IMPACT OF ECONOMIC DOWNTURN

When the economic crisis first started, vulnerable populations with the least access to healthcare would be the ones most negatively impacted by EU countries' attempts to contain their health and social spending.

Numerous issues have been brought about by economic crises in developing nations. A decline in economic growth, a drop in real household income and tax revenues, and a decline in tax revenues are some of the effects of an economic crisis at the national and individual levels. These effects are most pronounced in the Eastern Mediterranean region, where the economic crisis is concomitant with political crises.

MARKET SEGMENTATION

By Surgery

  • Intraventricular

  • Transcranial

  • Transnasal

Intraventricular segment accounted for the largest revenue share in 2022. B.Braun Medical Inc. and Medtronic are a few leading companies that offer intraventricular neuroendoscopy devices. Increasing cases of intraventricular hemorrhage and bleeding, and availability of technically advanced products are some of the key factors propelling the demand for these devices. Transcranial segment is expected to grow at the fastest CAGR during the forecast period of 2023-2030. Increasing cases of pituitary gland tumors, hydrocephalus, and macroadenomas are anticipated to accelerate the growth of the segment.

By Device type

  • Rigid

  • Flexible

Diseases like hydrocephalus, intraventricular tumours, and cystic lesions are treated with rigid neuroendoscopes. Consequently, rising rates of these illnesses fuel market expansion. Furthermore, there are versions of these devices that are smaller and lighter. As a result, there is a greater need for these devices, particularly when performing intraventricular surgeries.

The largest revenue share is accounted for by rigid neuroendoscopes. Most manufacturers depend on the inflexible neuroendoscopes. Diseases like hydrocephalus, intraventricular tumours, and cystic lesions are treated with rigid neuroendoscopes. The Hydrocephalus Association of the U.S. states that 1 to 2 out of every 1000 newborns has hydrocephalus. Thus, the need for rigid neuroendoscopes is driven by the increasing prevalence of these diseases.

By Application 

  • Hospitals

  • Medical Research Centers

A few of the factors driving the market growth are the government's numerous initiatives, the establishment of institutions to encourage the use of neuroendoscopy, and the rising R&D spending of the major players.

Hospitals hold the highest revenue share in the overall application segment. Because neuroendoscopy offers advantages like precise access to the target site, which is located in the interior parts of the brain, and minimally invasive procedures, hospitals are favoring it. Hospitals also record the highest number of neuroendoscopies performed annually because they have highly qualified personnel, neurosurgeons, and state-of-the-art emergency medical facilities. Hospitals are therefore the biggest sources of income.

REGIONAL ANALYSIS

The most developed market is in North America, which is followed by Europe. These markets are expanding as a result of rising pituitary tumor incidence and technological developments in the healthcare industry. Globally, the United States represents the largest market for neuroendoscopy. The benefits of these procedures, like the minimally invasive technique that allows patients to recover more quickly, are some of the main drivers behind their widespread use in the nation.

The Asia Pacific market is anticipated to experience substantial growth due to the abundance of unexplored growth prospects in the region, particularly in China, India, Japan, and other countries. Some of the factors propelling the growth of the Asia Pacific market are increased healthcare spending, greater technological advancements, and mandatory health insurance.

Neuroendoscopy-Market-By-Regio

Do You Need any Customization Research on Neuroendoscopy Market - Enquire Now

REGIONAL COVERAGE

North America

  • US

  • Canada

  • Mexico

Europe

  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of the Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

KEY PLAYERS

Some of the major key players of the Neuroendoscopy market are adeor medical AG (Germany), KARL STORZ SE & Co. KG (Germany), Medtronic (Ireland), B. Braun SE (Germany), Stryker (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation. (U.S.), Arthrex Inc. (U.S.) and other players.

adeor medical AG (Germany)-Company Financial Analysis

Company Landscape Analysis

Recent Trends in the Neuroendoscopy Market

  • The leading manufacturer of surgical equipment in Germany, Adeor Medical AG, and the international therapy-enabling platform company, ClearPoint Neuro Inc., partnered strategically and commercially in 2021. The objective was to provide delivery and navigation to the brain.

  • In August 2022, a team of American scientists discovered that neuroendoscopy can be a highly effective treatment option for patients with brain abscesses, yielding impressive outcomes. When compared to other Surgerys of methods, neuroendoscopic treatments for patients with brain abscesses have a greater number of curative effects, fewer complications, and a faster rate of post-operative recovery.

  • Evonos successfully showcased its evoDrill and evoFrame products during Neuroendoscopy Week 2021 at the Medical Centre of the Saarland University in Homburg-Saar, Germany, in September 2021. Evonos thinks that the neuroendoscopic and neurosurgical fields will progress with the successful demonstration of its products.

Neuroendoscopy Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 151.07 Million
Market Size by 2031  US$ 237.05 Million
CAGR   CAGR of 5.8% From 2024 to 2031
Base Year 2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Surgery (Intraventricular, Transcranial, Transnasal)
• By Device Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes)
• By Application (Hospitals, Medical Research Centers)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Company Profiles adeor medical AG (Germany), KARL STORZ SE & Co. KG (Germany), Medtronic (Ireland), B. Braun SE (Germany), Stryker (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation. (U.S.), Arthrex Inc. (U.S.)
Key Drivers • Growing Technological Advancements Made by Industry Participants
• Demand for Flexible Neuroendoscopes Is Growing
Market Restraint • Inadequate Professionals in Developing Nations, Exorbitant Surgical and Device Expenses

 

Frequently Asked Questions

Ans: The Neuroendoscopy market is expected to grow to a CAGR of 5.6%.

Ans: Neuroendoscopy market size was USD 142.8 million in 2022 and is expected to reach USD 220.8 million by 2030.

Ans: The market growth is driven by the Growing Technological Advancements Made by Industry Participants and Growing demand for Flexible Neuroendoscopes.

Ans: Inadequate Professionals in Developing Nations, Exorbitant Surgical and Device Expenses restraints market growth associated with Neuroendoscopy.

Ans: North America stood out as the dominated player in 2022.

TABLE OF CONTENTS

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges

5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8. Pest Analysis

9. Neuroendoscopy Market, By Surgery
9.1 Introduction
9.2 Trend Analysis
9.3 Intraventricular
9.4 Transcranial
9.5 Transnasal

10. Neuroendoscopy Market, By Device type
10.1 Introduction
10.2 Trend Analysis
10.3 Rigid Neuroendoscopes
10.4 Flexible Neuroendoscopes

11. Neuroendoscopy Market, By Application
11.1 Introduction
11.2 Trend Analysis
11.3 Hospitals
11.4 Medical Research Centers

12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America Neuroendoscopy Market by Country
12.2.3 North America Neuroendoscopy Market By Surgery
12.2.4 North America Neuroendoscopy Market By Device type
12.2.5 North America Neuroendoscopy Market By Application
12.2.6 USA
12.2.6.1 USA Neuroendoscopy Market By Surgery
12.2.6.2 USA Neuroendoscopy Market By Device type
12.2.6.3 USA Neuroendoscopy Market By Application
12.2.7 Canada
12.2.7.1 Canada Neuroendoscopy Market By Surgery
12.2.7.2 Canada Neuroendoscopy Market By Device type
12.2.7.3 Canada Neuroendoscopy Market By Application
12.2.8 Mexico
12.2.8.1 Mexico Neuroendoscopy Market By Surgery
12.2.8.2 Mexico Neuroendoscopy Market By Device type
12.2.8.3 Mexico Neuroendoscopy Market By Application
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe Neuroendoscopy Market by Country
12.3.2.2 Eastern Europe Neuroendoscopy Market By Surgery
12.3.2.3 Eastern Europe Neuroendoscopy Market By Device type
12.3.2.4 Eastern Europe Neuroendoscopy Market By Application
12.3.2.5 Poland
12.3.2.5.1 Poland Neuroendoscopy Market By Surgery
12.3.2.5.2 Poland Neuroendoscopy Market By Device type
12.3.2.5.3 Poland Neuroendoscopy Market By Application
12.3.2.6 Romania
12.3.2.6.1 Romania Neuroendoscopy Market By Surgery
12.3.2.6.2 Romania Neuroendoscopy Market By Device type
12.3.2.6.4 Romania Neuroendoscopy Market By Application
12.3.2.7 Hungary
12.3.2.7.1 Hungary Neuroendoscopy Market By Surgery
12.3.2.7.2 Hungary Neuroendoscopy Market By Device type
12.3.2.7.3 Hungary Neuroendoscopy Market By Application
12.3.2.8 Turkey
12.3.2.8.1 Turkey Neuroendoscopy Market By Surgery
12.3.2.8.2 Turkey Neuroendoscopy Market By Device type
12.3.2.8.3 Turkey Neuroendoscopy Market By Application
12.3.2.9 Rest of Eastern Europe
12.3.2.9.1 Rest of Eastern Europe Neuroendoscopy Market By Surgery
12.3.2.9.2 Rest of Eastern Europe Neuroendoscopy Market By Device type
12.3.2.9.3 Rest of Eastern Europe Neuroendoscopy Market By Application
12.3.3 Western Europe
12.3.3.1 Western Europe Neuroendoscopy Market by Country
12.3.3.2 Western Europe Neuroendoscopy Market By Surgery
12.3.3.3 Western Europe Neuroendoscopy Market By Device type
12.3.3.4 Western Europe Neuroendoscopy Market By Application
12.3.3.5 Germany
12.3.3.5.1 Germany Neuroendoscopy Market By Surgery
12.3.3.5.2 Germany Neuroendoscopy Market By Device type
12.3.3.5.3 Germany Neuroendoscopy Market By Application
12.3.3.6 France
12.3.3.6.1 France Neuroendoscopy Market By Surgery
12.3.3.6.2 France Neuroendoscopy Market By Device type
12.3.3.6.3 France Neuroendoscopy Market By Application
12.3.3.7 UK
12.3.3.7.1 UK Neuroendoscopy Market By Surgery
12.3.3.7.2 UK Neuroendoscopy Market By Device type
12.3.3.7.3 UK Neuroendoscopy Market By Application
12.3.3.8 Italy
12.3.3.8.1 Italy Neuroendoscopy Market By Surgery
12.3.3.8.2 Italy Neuroendoscopy Market By Device type
12.3.3.8.3 Italy Neuroendoscopy Market By Application
12.3.3.9 Spain
12.3.3.9.1 Spain Neuroendoscopy Market By Surgery
12.3.3.9.2 Spain Neuroendoscopy Market By Device type
12.3.3.9.3 Spain Neuroendoscopy Market By Application
12.3.3.10 Netherlands
12.3.3.10.1 Netherlands Neuroendoscopy Market By Surgery
12.3.3.10.2 Netherlands Neuroendoscopy Market By Device type
12.3.3.10.3 Netherlands Neuroendoscopy Market By Application
12.3.3.11 Switzerland
12.3.3.11.1 Switzerland Neuroendoscopy Market By Surgery
12.3.3.11.2 Switzerland Neuroendoscopy Market By Device type
12.3.3.11.3 Switzerland Neuroendoscopy Market By Application
12.3.3.1.12 Austria
12.3.3.12.1 Austria Neuroendoscopy Market By Surgery
12.3.3.12.2 Austria Neuroendoscopy Market By Device type
12.3.3.12.3 Austria Neuroendoscopy Market By Application
12.3.3.13 Rest of Western Europe
12.3.3.13.1 Rest of Western Europe Neuroendoscopy Market By Surgery
12.3.3.13.2 Rest of Western Europe Neuroendoscopy Market By Device type
12.3.3.13.3 Rest of Western Europe Neuroendoscopy Market By Application
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific Neuroendoscopy Market by Country
12.4.3 Asia-Pacific Neuroendoscopy Market By Surgery
12.4.4 Asia-Pacific Neuroendoscopy Market By Device type
12.4.5 Asia-Pacific Neuroendoscopy Market By Application
12.4.6 China
12.4.6.1 China Neuroendoscopy Market By Surgery
12.4.6.2 China Neuroendoscopy Market By Device type
12.4.6.3 China Neuroendoscopy Market By Application
12.4.7 India
12.4.7.1 India Neuroendoscopy Market By Surgery
12.4.7.2 India Neuroendoscopy Market By Device type
12.4.7.3 India Neuroendoscopy Market By Application
12.4.8 Japan
12.4.8.1 Japan Neuroendoscopy Market By Surgery
12.4.8.2 Japan Neuroendoscopy Market By Device type
12.4.8.3 Japan Neuroendoscopy Market By Application
12.4.9 South Korea
12.4.9.1 South Korea Neuroendoscopy Market By Surgery
12.4.9.2 South Korea Neuroendoscopy Market By Device type
12.4.9.3 South Korea Neuroendoscopy Market By Application
12.4.10 Vietnam
12.4.10.1 Vietnam Neuroendoscopy Market By Surgery
12.4.10.2 Vietnam Neuroendoscopy Market By Device type
12.4.10.3 Vietnam Neuroendoscopy Market By Application
12.4.11 Singapore
12.4.11.1 Singapore Neuroendoscopy Market By Surgery
12.4.11.2 Singapore Neuroendoscopy Market By Device type
12.4.11.3 Singapore Neuroendoscopy Market By Application
12.4.12 Australia
12.4.12.1 Australia Neuroendoscopy Market By Surgery
12.4.12.2 Australia Neuroendoscopy Market By Device type
12.4.12.3 Australia Neuroendoscopy Market By Application
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Neuroendoscopy Market By Surgery
12.4.13.2 Rest of Asia-Pacific Neuroendoscopy Market By Device type
12.4.13.3 Rest of Asia-Pacific Neuroendoscopy Market By Application
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East Neuroendoscopy Market by Country
12.5.2.2 Middle East Neuroendoscopy Market By Surgery
12.5.2.3 Middle East Neuroendoscopy Market By Device type
12.5.2.4 Middle East Neuroendoscopy Market By Application
12.5.2.5 UAE
12.5.2.5.1 UAE Neuroendoscopy Market By Surgery
12.5.2.5.2 UAE Neuroendoscopy Market By Device type
12.5.2.5.3 UAE Neuroendoscopy Market By Application
12.5.2.6 Egypt
12.5.2.6.1 Egypt Neuroendoscopy Market By Surgery
12.5.2.6.2 Egypt Neuroendoscopy Market By Device type
12.5.2.6.3 Egypt Neuroendoscopy Market By Application
12.5.2.7 Saudi Arabia
12.5.2.7.1 Saudi Arabia Neuroendoscopy Market By Surgery
12.5.2.7.2 Saudi Arabia Neuroendoscopy Market By Device type
12.5.2.7.3 Saudi Arabia Neuroendoscopy Market By Application
12.5.2.8 Qatar
12.5.2.8.1 Qatar Neuroendoscopy Market By Surgery
12.5.2.8.2 Qatar Neuroendoscopy Market By Device type
12.5.2.8.3 Qatar Neuroendoscopy Market By Application
12.5.2.9 Rest of Middle East
12.5.2.9.1 Rest of Middle East Neuroendoscopy Market By Surgery
12.5.2.9.2 Rest of Middle East Neuroendoscopy Market By Device type
12.5.2.9.3 Rest of Middle East Neuroendoscopy Market By Application
12.5.3 Africa
12.5.3.1 Africa Neuroendoscopy Market by Country
12.5.3.2 Africa Neuroendoscopy Market By Surgery
12.5.3.3 Africa Neuroendoscopy Market By Device type
12.5.3.4 Africa Neuroendoscopy Market By Application
12.5.3.5 Nigeria
12.5.3.5.1 Nigeria Neuroendoscopy Market By Surgery
12.5.3.5.2 Nigeria Neuroendoscopy Market By Device type
12.5.3.5.3 Nigeria Neuroendoscopy Market By Application
12.5.3.6 South Africa
12.5.3.6.1 South Africa Neuroendoscopy Market By Surgery
12.5.3.6.2 South Africa Neuroendoscopy Market By Device type
12.5.3.6.3 South Africa Neuroendoscopy Market By Application
12.5.3.7 Rest of Africa
12.5.3.7.1 Rest of Africa Neuroendoscopy Market By Surgery
12.5.3.7.2 Rest of Africa Neuroendoscopy Market By Device type
12.5.3.7.3 Rest of Africa Neuroendoscopy Market By Application
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America Neuroendoscopy Market by country
12.6.3 Latin America Neuroendoscopy Market By Surgery
12.6.4 Latin America Neuroendoscopy Market By Device type
12.6.5 Latin America Neuroendoscopy Market By Application
12.6.6 Brazil
12.6.6.1 Brazil Neuroendoscopy Market By Surgery
12.6.6.2 Brazil Neuroendoscopy Market By Device type
12.6.6.3 Brazil Neuroendoscopy Market By Application
12.6.7 Argentina
12.6.7.1 Argentina Neuroendoscopy Market By Surgery
12.6.7.2 Argentina Neuroendoscopy Market By Device type
12.6.7.3 Argentina Neuroendoscopy Market By Application
12.6.8 Colombia
12.6.8.1 Colombia Neuroendoscopy Market By Surgery
12.6.8.2 Colombia Neuroendoscopy Market By Device type
12.6.8.3 Colombia Neuroendoscopy Market By Application
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Neuroendoscopy Market By Surgery
12.6.9.2 Rest of Latin America Neuroendoscopy Market By Device type
12.6.9.3 Rest of Latin America Neuroendoscopy Market By Application

13. Company Profiles
13.1 adeor medical AG (Germany)

13.1.1 Company Overview
13.1.2 Financial
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 KARL STORZ SE & Co. KG (Germany)
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Medtronic (Ireland)
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 B. Braun SE (Germany)
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Stryker (U.S.)
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Boston Scientific Corporation (U.S.)
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 CONMED Corporation. (U.S.)
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Arthrex Inc. (U.S.)
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View

14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions

15. Use Case and Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone